Analytical Data
-
Gene name
CSTL1
- Application
-
Alternative Names
Cystatin-like 1; RCET11; CSTL1
-
Species
Human
-
Source
HEK293
-
Tag
C-hFc
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q9H114
-
Expression Region
A20-R145
-
Protein Length
Full Length of Mature Protein
-
Molecular Weight
45-80 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CSTL1, or the Cystatin-like protein 1, is a member of the cystatin superfamily, which plays a critical role in regulating proteolytic enzymes and maintaining protein homeostasis in biological systems. Research on CSTL1 has gained interest due to its potential involvement in various physiological processes and disease states, particularly in cancer and inflammatory responses. Numerous studies have indicated that CSTL1 may act as a tumor suppressor, inhibiting cell proliferation and metastasis, making it a target of interest in cancer therapy. Its expression levels have been correlated with patient outcomes in several malignancies, prompting investigations into the mechanisms by which CSTL1 modulates tumor biology. Additionally, CSTL1’s interaction with other cellular pathways positions it as a key player in both innate immune responses and tissue remodeling. Furthermore, the recombinant production of CSTL1 protein facilitates detailed functional assays and structural studies, paving the way for the development of novel therapeutic strategies. Understanding the biological functions and molecular mechanisms of CSTL1 can provide valuable insights into its role in health and disease, thereby advancing potential clinical applications in diagnostics and targeted therapies. Consequently, the ongoing research into CSTL1 not only elucidates its fundamental biological roles but also holds promise for innovative approaches to managing various diseases.
